(Q34743475)

English

Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Virginia Filiaci

object named as

Virginia Filiaci

2

0 references

David Scott Miller

object named as

David Scott Miller

8

0 references

Angeles Alvarez Secord

5

object named as

Angeles Alvarez Secord

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Raymond J Osborne

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Julian C Schink

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Robert S Mannel

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Joseph L Kelley

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Diane Provencher

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Allan L Covens

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Janice M Lage

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

24 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

825-831

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

Gestational trophoblastic neoplasia and evidence-based medicine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

5-day methotrexate for women with metastatic gestational trophoblastic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

The alpha spending function approach to interim data analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

Treatment of nonmetastatic gestational trophoblastic disease: Results of methotrexate alone versus methotrexate-folinic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

Actinomycin D as the primary agent for gestational trophoblastic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

7 July 2018

Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

26 October 2018

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

26 October 2018

Better treatments that cost more: the dilemma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068058

26 October 2018

Methotrexate infusion in low-risk gestational trophoblastic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: Cost-effective chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose actinomycin D in the treatment of postmolar trophoblastic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-Dose Methotrexate for Gestational Trophoblastic Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2010.30.4386

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34743475&oldid=1648881785"